Cleared Traditional

K833805 - GLYCOGLOBIN KIT

K833805 is the FDA 510(k) clearance for GLYCOGLOBIN KIT by Endocrine Sciences Products. It is a Class 2 Hematology device (product code LCP) cleared through the Traditional 510(k) pathway after a 63-day FDA review.

K833805 · Endocrine Sciences Products · Hematology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 1984
Decision
63d
Days
Class 2
Risk

K833805 is an FDA 510(k) clearance for the GLYCOGLOBIN KIT. Classified as Assay, Glycosylated Hemoglobin (product code LCP), Class II - Special Controls.

Submitted by Endocrine Sciences Products (Mchenry, US). The FDA issued a Cleared decision on January 3, 1984 after a review of 63 days - a notably fast clearance cycle.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.7470 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Endocrine Sciences Products devices

Submission Details

510(k) Number K833805 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 01, 1983
Decision Date January 03, 1984
Days to Decision 63 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
50d faster than avg
Panel avg: 113d · This submission: 63d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LCP Assay, Glycosylated Hemoglobin
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.7470
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - LCP Assay, Glycosylated Hemoglobin

All 143
Devices cleared under the same product code (LCP) and FDA review panel - the closest regulatory comparables to K833805.
GLYCO-TEK AFFINITY COLUMN
K842689 · Helena Laboratories · Oct 1984
ELTRACHEM DIATRAC GLYCOSYLATED HEMOGLOB
K834294 · Emd Chemicals, Inc. · Jan 1984
AUTO AIC ANALYZER SYSTEM
K833772 · Helena Laboratories · Jan 1984
GLYCO-JE,E CPMTRP
K833356 · Helena Laboratories · Nov 1983
A-GENT GLYCOSYLATED HEMOGLOBIN
K832775 · Abbott Laboratories · Sep 1983
TITAN GEL GLYCO-HEME SYSTEM
K832087 · Helena Laboratories · Aug 1983